LLY compared with KYNB: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

KYNBKyntra Bio, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

KYNBKyntra Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only KYNB 10

AZNAstraZeneca AB ("AstraZeneca")customer

—Astellas Pharma Inc. ("Astellas")unlistedsupplier

—Fortis Therapeutics, Inc. ("Fortis")unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Shanghai SynTheAll Pharmaceutical Co., Ltd. ("WuXi STA")

unlistedsupplier

6 more · KYNB chain ›

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

KYNBKyntra Bio, Inc.

3.660.00%

ClosedNov 6 '26

Mkt cap$15.1MRevenue$4MQ1 FY26Revenue$6MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

KYNBKyntra Bio, Inc.

1,360.90▼−0.28%post 1,358.90

Price

3.660.00%

$1.2T

Mkt cap

$15.1M

Q3 FY26$24.4B

Revenue

$4MQ1 FY26

FY25$65.2B

Revenue

$6MFY25

LLY1,360.90▼−0.28%vsKYNB3.660.00%ClosedNov 6 '26